We are delighted to announce that Kossel’s High-Pressure Percutaneous Transluminal Angioplasty (HP PTA) Balloon Dilatation Catheter has received approval from the United States Food and Drug Administration (USFDA). This significant milestone marks a major achievement for Kossel and reinforces our commitment to advancing medical technologies for the benefit of patients worldwide.
The USFDA approval is a testament to the safety and efficacy of the Kossel HP PTA Balloon Dilatation Catheter, highlighting its compliance with rigorous regulatory standards. This catheter is designed to address the evolving needs of healthcare professionals, providing them with a state-of-the-art tool for percutaneous transluminal angioplasty procedures.
